Andrew Davis to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Andrew Davis has written about Adrenergic beta-Antagonists.
Connection Strength
0.229
-
Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study. Circulation. 2018 07 03; 138(1):29-36.
Score: 0.132
-
Management of Patients With Chronic Coronary Disease. JAMA. 2024 08 20; 332(7):585-586.
Score: 0.052
-
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With ß-Blockers. JAMA Cardiol. 2022 05 01; 7(5):504-512.
Score: 0.044